Dominik Wolf‎

ORCID: 0000-0002-4761-075X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Immune Cell Function and Interaction
  • Eosinophilic Disorders and Syndromes
  • Hematopoietic Stem Cell Transplantation
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Functional Brain Connectivity Studies
  • Multiple Myeloma Research and Treatments
  • T-cell and B-cell Immunology
  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Dementia and Cognitive Impairment Research
  • Single-cell and spatial transcriptomics
  • Pancreatic and Hepatic Oncology Research
  • Immune cells in cancer
  • Advanced Neuroimaging Techniques and Applications
  • COVID-19 Clinical Research Studies
  • Kruppel-like factors research
  • Cancer Cells and Metastasis
  • Cytokine Signaling Pathways and Interactions
  • Acute Lymphoblastic Leukemia research

Innsbruck Medical University
2016-2025

Tyrolean Cancer Research Institute
2015-2025

University Hospital Bonn
2015-2024

Universität Innsbruck
2015-2024

University Hospital Innsbruck
2004-2024

University of Bonn
2011-2024

Johannes Gutenberg University Mainz
2015-2024

University Medical Center of the Johannes Gutenberg University Mainz
2015-2024

Austrian Breast & Colorectal Cancer Study Group
2008-2023

University Hospital Dubrava
2023

Abstract Purpose: The forkhead box transcription factor FoxP3 is specifically expressed in T cells with regulatory properties (Treg). Recently, high numbers of Treg were described to be associated poor survival different malignancies. aim the presented study was determine prognostic effect mRNA expression (reflecting tissue content Treg) ovarian carcinoma and its relation cytokines, such as IFN-γ. Experimental Design: Total RNA isolated from 99 14 healthy biopsies. Real-time PCR for done...

10.1158/1078-0432.ccr-05-1244 article EN Clinical Cancer Research 2005-12-01

PURPOSE Despite undergoing allogeneic hematopoietic stem cell transplantation (HCT), patients with acute myeloid leukemia (AML) internal tandem duplication mutation in the FMS-like tyrosine kinase 3 gene ( FLT3-ITD) have a poor prognosis, frequently relapse, and die as result of AML. It is currently unknown whether maintenance therapy using FLT3 inhibitors, such multitargeted inhibitor sorafenib, improves outcome after HCT. PATIENTS AND METHODS In randomized, placebo-controlled, double-blind...

10.1200/jco.19.03345 article EN Journal of Clinical Oncology 2020-07-16

To assess the potential role of FoxP3-expressing regulatory T cells (Tregs) in reversing obesity-linked insulin resistance and diabetic nephropathy rodent models humans.To characterize Tregs resistance, human visceral adipose tissue was first evaluated for Treg infiltration second, db/db mouse model evaluated.Obese patients with displayed significantly decreased natural but an increase adaptive their as compared lean control subjects. further evaluate pathogenic used. depletion using...

10.2337/db11-0358 article EN cc-by-nc-nd Diabetes 2011-09-13
Nimitha R. Mathew Francis Baumgartner Lukas M. Braun David O’Sullivan Simone Thomas and 95 more Miguel Waterhouse Tony Andreas Müller Kathrin Hanke Sanaz Taromi Petya Apostolova Anna Lena Illert Wolfgang Melchinger Sandra Duquesne Annette Schmitt‐Graeff Lena Oßwald Kaili Yan Arnim Weber Sònia Tugues Sabine Spath Dietmar Pfeifer Marie Follo Rainer Claus Michael Lübbert Christoph Rummelt Hartmut Bertz Ralph Wäsch Johanna Haag Andrea Schmidts Michael Schultheiß Dominik Bettinger Robert Thimme Evelyn Ullrich Yakup Tanriver Giang Lam Vuong Renate Arnold Philipp Hemmati Dominik Wolf‎ Markus Ditschkowski Cordula A. Jilg Konrad Wilhelm Christian Leiber Sabine Gerull Jörg Halter Claudia Lengerke Thomas Pabst Thomas Schroeder Guido Kobbe Wolf Rösler Soroush Doostkam Stephan Meckel Kathleen Stabla Stephan Metzelder Sebastian Halbach Tilman Brummer Zehan Hu Jörn Dengjel Björn Hackanson Christoph Schmid Udo Holtick Christof Scheid Alexandros Spyridonidis Friedrich Stölzel Rainer Ordemann Lutz Müller Flore Sicre-de-Fontbrune Gabriele Ihorst Jürgen Kuball Jan E. Ehlert Daniel Feger Eva-Maria Wagner Jean‐Yves Cahn Jacqueline Schnell Florian Kuchenbauer Donald Bunjes Ronjon Chakraverty Simon Richardson Saar Gill Nicolaus Kröger Francis Ayuk Luca Vago Fabio Ciceri A Müller Takeshi Kondo Takanori Teshima Susan Klaeger Bernhard Küster Dennis Dong Hwan Kim Daniel J. Weisdorf Walter J. F. M. van der Velden Daniela Dörfel Wolfgang Bethge Inken Hilgendorf Andreas Hochhaus Geoffroy Andrieux Melanie Börries Hauke Busch John Magenau Pavan Reddy Myriam Labopin Joseph H. Antin

10.1038/nm.4484 article EN Nature Medicine 2018-02-12

Non-small cell lung cancer (NSCLC) is characterized by molecular heterogeneity with diverse immune infiltration patterns, which has been linked to therapy sensitivity and resistance. However, full understanding of how phenotypes vary across different patient subgroups lacking. Here, we dissect the NSCLC tumor microenvironment at high resolution integrating 1,283,972 single cells from 556 samples 318 patients 29 datasets, including our dataset capturing low mRNA content. We stratify into...

10.1016/j.ccell.2022.10.008 article EN cc-by Cancer Cell 2022-11-10

Abstract Personalized medicine aims to match the right drug with patient by using specific features of individual patient's tumor. However, current strategies personalized therapy matching provide treatment opportunities for less than 10% patients cancer. A promising method may be profiling biopsy specimens single-cell resolution directly quantify effects. We prospectively tested an image-based functional precision (scFPM) approach guide treatments in 143 advanced aggressive hematologic...

10.1158/2159-8290.cd-21-0538 article EN cc-by-nc-nd Cancer Discovery 2021-10-11

Abstract Background Crosstalk between neoplastic and stromal cells fosters prostate cancer (PCa) progression dissemination. Insight in cell-to-cell communication networks provides new therapeutic avenues to mold processes that contribute PCa tumor microenvironment (TME) alterations. Here we performed a detailed characterization of endothelial (TEC) delineate intercellular crosstalk TEC the TME. Methods isolated from 67 fresh radical prostatectomy (RP) specimens underwent multi-omic ex vivo...

10.1186/s12943-022-01597-7 article EN cc-by Molecular Cancer 2022-06-18

Normothermic machine perfusion (NMP) has emerged as an innovative organ preservation technique. Developing understanding for the donor immune cell composition and its dynamic changes during NMP is essential. We aimed a comprehensive characterization of (sub)populations, trafficking cytokine release liver NMP. Single-cell transcriptome profiling human livers prior to, after transplantation shows abundance CXC chemokine receptor 1+/2+ (CXCR1+/CXCR2+) neutrophils, which significantly decreased...

10.1038/s41467-023-37674-8 article EN cc-by Nature Communications 2023-04-21

Abstract Background An international Delphi panel has defined a harmonized protocol (HarP) for the manual segmentation of hippocampus on MR. The aim this study is to concurrent validity HarP toward local protocols, and its major sources variance. Methods Fourteen tracers segmented 10 Alzheimer's Disease Neuroimaging Initiative (ADNI) cases scanned at 1.5 T 3T following qualified based through standard web‐platform resegmented HarP. five most accurate followed segment 15 ADNI acquired three...

10.1016/j.jalz.2014.05.1756 article EN Alzheimer s & Dementia 2014-09-27

CD4+CD25+ regulatory T cells (Treg) are of critical importance for the maintenance tolerance. The kidney is frequently involved in autoimmune diseases, such as lupus erythematosus or glomerulonephritis (GN). Therefore, therapeutic efficacy Treg a cell-dependent murine model experimental anti-glomerular basement membrane (anti-GBM) GN was tested. Transfer 1 x 10(6) (day -1) into mice that were previously immunized with rabbit IgG -3) and subsequently received an injection anti-GBM serum 0)...

10.1681/asn.2004100837 article EN Journal of the American Society of Nephrology 2005-03-24

To expand the current knowledge about azacitidine (Aza) and donor lymphocyte infusions (DLI) as salvage therapy for relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) to identify predictors response survival, we retrospectively analyzed data of 154 patients with acute myeloid leukemia (AML, n = 124), myelodysplastic (MDS, 28), or myeloproliferative syndrome (n 2). All received a median number 4 courses Aza (range, 14) DLI were administered 105 (68%; DLI, 2; range, 1...

10.1016/j.bbmt.2014.12.016 article EN cc-by-nc-nd Biology of Blood and Marrow Transplantation 2014-12-23

Both mast cells (MCs) and regulatory T (Tregs) have gained attention as immunosuppressive cell populations. To investigate a possible interaction, we used the Th1- Th17-dependent model of nephrotoxic serum nephritis (NTS), in which both MCs Tregs been shown to play protective role. Transfer wild-type (wt) into wt recipients almost completely prevents development NTS leads profound increase renal draining lymph nodes (LNs). By contrast, transfer animals deficient MCs, are characterized by an...

10.4049/jimmunol.1001183 article EN The Journal of Immunology 2010-11-30

Ruxolitinib is a small-molecule inhibitor of the JAK kinases, which has been approved for treatment myelofibrosis, rare myeloproliferative neoplasm (MPN), but clinical trials are also being conducted in inflammatory-driven solid tumors. Increased infection rates have reported ruxolitinib-treated patients, and natural killer (NK) cells immune effector known to eliminate both virus-infected malignant cells. On this basis, we sought compare effects inhibition on human NK cohort 28 MPN patients...

10.1158/0008-5472.can-14-3198 article EN Cancer Research 2015-04-02
Coming Soon ...